can semaglutide cause a heart attack In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for failure or all-cause mortality vs sitagliptin, but tirzepatide offered no additional benefit over semaglutide. https://ja.ma/3JO2SQc Evaluating the Cardiovascular Benefits of

Patients with kidney disease, Leber's disease, megaloblastic anemia, and breastfeeding women should discuss the benefits and risks and dosage with their doctor

Personal Med Psych 19:100042

So, how are you supposed to maintain your hard-won results

[1] [2] This medication works by mimicking the action of endogenous GLP-1, enhancing glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting satiety through central nervous system pathways

doi: 10.1371/journal.pone.0123454

Here we aimed to determine whether sequence differences at the ligand C-termini of clinically approved GLP-1RAs exendin-4 and lixisenatide lead to similar phenomena